Irinotecan Hydrochloide Injection
Product Images NDC 68001-480

This is a description for a medication called Irinotecan Hydrochloride Injection. It is a sterile aqueous solution that is for intravenous use only and must be diluted before use. The medication comes in a single-dose vial and caution needs to be taken as it is a cytotoxic agent. It needs to be stored between 20-25°C, protected from light and freezing, and should be discarded if it is damaged or leaking. The dosage and use instructions are not provided and should be obtained from the accompanying prescribing information. Each mL of Irinotecan Hydrochloride Injection contains 20 mg of irinotecan hydrochloride trihydrate, 45 mg of sorbitol, and 0.9 mg of lactic acid along with water for injection. It is manufactured by Gland Pharma Limited in India and distributed by BluePoint Laboratories.*

This is a description of a medication called Irinotecan Hydrochloride Injection, USP, which comes in a 100mg/5mL single-dose vial. The medication is a cytotoxic agent and is only for intravenous use. It is a sterile, aqueous solution that must be diluted before use. The medication should be stored at 20 to 25°C (68 to 77°F) and protected from light and freezing. If the contents are damaged or leaking, the entire package should be incinerated. The dosage and use of the medication should be referred to the prescribing information. Each mL of the medication contains irinotecan hydrochloride trihydrate, sorbitol, lactic acid, and water for injection with necessary pH adjustments made with sodium hydroxide and/or hydrochloric acid. The product is manufactured by Gland Pharma Ltd in India and distributed by BluePoint Laboratories.*

Irinotecan Hydrochloride Injection, USP is a cytotoxic agent that is supplied in a 40 mg/2 mL single-dose vial by Gland Pharma Ltd in Andhra Pradesh, India. The medication is for intravenous use only and must be diluted before use. The dosage instructions and other essential details can be found on the insert provided. The product is distributed by BluePoint Laboratories with an NDC number of 68001-480-35. The lot number and expiration date should be checked before administering the medication.*

This is a description of a medication in the form of an injectable solution. It should be stored between 20° and 25°C, protected from light, and not frozen. The medication is manufactured by Gland Pharma Ltd in India and distributed by BluePoint Laboratories. The medication's dosage and usage information can be found in the accompanying prescribing information. The medication contains Irinotecan Hydrochloride and is labeled as a cytotoxic agent. The package contains a single-dose vial that must be diluted before use. The lot and expiration date are not provided in the text.*

This text provides information about a medical study of a medication called Innotecan 5-FU. The numbers "N 127 129" likely refer to the number of participants in the study. The study had a median follow-up time of 15 months. The final line shows that there is a median value being reported, but it is unclear what this value is referring to without more context.*

I'm sorry, the given text is incomplete. It only consists of a drug name "Irinotecan Hydrochloride." It is a chemotherapy medication used to treat various types of cancer, including colorectal, pancreatic, and lung cancer. It works by inhibiting the action of an enzyme called topoisomerase I, which is involved in DNA replication and cell division. However, it can have various side effects, such as nausea, vomiting, diarrhea, hair loss, fever, and blood disorders. It should only be used under the supervision of a qualified healthcare provider.*